Primary Record
Mra-CN
- In stock
- 4,663 g
- Purity
- 98.1 %
- CAS
- 88254-07-3
Compound Identifiers & Properties
- CAS
- 88254-07-3
- PubChem CID
- 337854
- SMILES
- CC1C(C(CC(O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N6CCOCC6C#N)O
- Canonical SMILES
- COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3OC1CC(N2CCOCC2C#N)C(O)C(C)O1
Names & Synonyms
- Mra-CN
- Cyanomorpholinoadriamycin
- cyanomorpholino doxorubicin
- AC1L7ML5
- CCRIS 5080
- CHEMBL278828
- C32H34N2O12
- CID337854
- MRA-CN isomer a, a:b = 93:7
- NSC357704
- C32-H34-N2-O12
- NSC 357704
- NSC-357704
- BRN 6050053
- NCI60_003240
- 3'-(3-Cyano-4-morpholinyl)-3'-deamino-adriamycin
- 3'-Deamino-3'-(3-cyano-4-morpholinyl)doxorubicin
- 88254-07-3
- 4-[3-hydroxy-2-methyl-6-[[(1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl]oxy]oxan-4-yl]morpholine-3-carbonitrile
- 5, 10-[[3-(3-cyano-4-morpholinyl)-2,3,6-trideoxy-.alpha.- L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11- trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)-
- 5,12-Naphthacenedione, 10-[[3-(3-cyano-4-morpholinyl)-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-